MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tam, W. F.
Right arrow Articles by Sen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, W. F.
Right arrow Articles by Sen, R.

 Previous Article

Molecular and Cellular Biology, July 2001, p. 4837-4846, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4837-4846.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Cell-Specific Association and Shuttling of Ikappa Balpha Provides a Mechanism for Nuclear NF-kappa B in B Lymphocytes

Winnie F. Tam, Weihong Wang,dagger and Ranjan Sen*

Rosenstiel Basic Medical Sciences Research Center and Department of Biology, Brandeis University, Waltham, Massachusetts 02454

Received 20 December 2000/Returned for modification 18 February 2001/Accepted 9 April 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Mature B lymphocytes are unique in containing nuclear Rel proteins prior to cell stimulation. This activity consists largely of p50-c-Rel heterodimers, and its importance for B-cell function is exemplified by reduced B-cell viability in several genetically altered mouse strains. Here we suggest a mechanism for the cell specificity and the subunit composition of constitutive B-cell NF-kappa B based on the observed properties of Rel homo- and heterodimers and Ikappa Balpha . We show that c-Rel lacks a nuclear export sequence, making the removal of c-Rel-containing complexes from the nucleus less efficient than removal of p65-containing complexes. Second, the nuclear import potential of p65 and c-Rel homodimers but not p50-associated heterodimers was attenuated when they were complexed to Ikappa Balpha , leading to a greater propensity of heterodimers to be nuclear. We propose that subunit composition of B-cell NF-kappa B reflects the inefficient retrieval of p50-c-Rel heterodimers from the nucleus. Cell specificity may be a consequence of c-Rel-Ikappa Balpha complexes being present only in mature B cells, which leads to nuclear c-Rel due to Ikappa Balpha turnover and shuttling of the complex.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The Rel family of transcription factors regulate inducible gene transcription (11, 34). These proteins share an approximately 300 amino acid domain at the N terminus, the Rel homology domain (RHD), which is used for protein-protein interactions and DNA binding. Homo- or heterodimerization between Rel family members is essential for DNA binding and interactions with the regulatory Ikappa B proteins which inhibit DNA binding and localize Rel proteins to the cell cytoplasm. In most cells, Rel proteins are located in the cell cytoplasm complexed to one of three Ikappa B proteins---Ikappa Balpha , Ikappa Bbeta , or Ikappa Bvarepsilon (15, 25, 28, 44). Upon cell stimulation, Ikappa Bs are phosphorylated at their N termini by Ikappa B kinases, which targets them for proteasome-mediated degradation. This leaves the Rel proteins free to translocate to the nucleus and activate gene expression. Rel protein-dependent gene expression must be strictly controlled, as exemplified by the phenotype of Ikappa Balpha -deficient mice (3, 24). These animals die soon after birth, presumably due to aberrant gene activation. Thus, regulation of DNA binding and subcellular distribution of Rel proteins by Ikappa Bs is a critical aspect of the biology of these transcription factors.

The three Ikappa Bs retain Rel proteins in the cytoplasm by different mechanisms. Ikappa Balpha , but not Ikappa Bbeta or Ikappa Bvarepsilon , contains a strong nuclear export sequence (NES), and cytoplasmic location of p65-RelA by Ikappa Balpha has been shown to require nuclear export via the exportin CRM1 (16, 19, 42). Specifically, inhibition of nuclear export by mutating the Ikappa Balpha NES or affecting CRM1 function genetically or pharmacologically leads to nuclear accumulation of p65-Ikappa Balpha complexes (16, 19, 42). Based on such studies, the current model is that cytoplasmic localization by Ikappa Balpha is a dynamic process, with Ikappa Balpha -containing complexes shuttling between the nucleus and the cytoplasm. Presumably, the net cytoplasmic appearance of these complexes occurs because the balance between nuclear entry and exit is tilted in favor of the latter.

In contrast, Ikappa Bbeta and Ikappa Bvarepsilon localize Rel proteins to the cytoplasm as effectively as Ikappa Balpha but do not contain identifiable NESs. We have shown that nuclear export is not involved in this process and suggested that cytoplasmic localization by Ikappa Bbeta and Ikappa Bvarepsilon reflects sequestration of Rel proteins (43). That is, Rel-Ikappa Bbeta (or -Ikappa Bvarepsilon ) complexes are cytoplasmic because they never make it into the nucleus. Furthermore, even when nuclear p65-Ikappa Bbeta complexes were created by sequential expression of p65 followed by Ikappa Bbeta , export of this complex to the cytoplasm was inefficient (43). Shuttling of Ikappa Balpha -associated complexes but not Ikappa Bbeta -associated complexes implies that there is residual nuclear localization sequence (NLS) activity in Ikappa Balpha complexes. Our working model is that Ikappa Bbeta association must hide the Rel NLSs more effectively.

Mature B lymphocytes are unique in containing nuclear Rel proteins prior to cell stimulation. The constitutive nuclear activity consists of p50-c-Rel heterodimers (13, 22, 27, 30), and its importance for B-cell function is exemplified by the lower viability of B cells from p50-deficient and xid mice, both of which have decreased constitutive NF-kappa B (2, 7, 20, 21, 23, 38, 39, 41). In c-Rel-deficient mice, p50-p65 (NF-kappa B) heterodimer levels are elevated in splenic B cells, suggesting that lack of p50-c-Rel heterodimers must be compensated for (10, 26). Moreover, B-cell viability is severely decreased in p65-c-Rel double-deficient mice (12). Several models have been proposed to explain the presence of nuclear NF-kappa B in B cells, such as increased turnover rate of Ikappa Balpha in WEHI 231 cells (29) and protection of nuclear NF-kappa B by Ikappa Bbeta (36). Miyamoto and colleagues have provided much of the support for the turnover model, in particular the recent demonstration that intracellular calcium controls Ikappa Balpha degradation in mature B cells (9, 31, 40). However, the importance of Ikappa Balpha half-life for constitutive nuclear NF-kappa B has not been directly demonstrated. Indeed, there is some evidence that Ikappa Balpha is not turned over as fast in immunoglobulin G (IgG)-positive B cells, yet there is constitutive NF-kappa B in the nucleus (6). Finally, it is not clear why the constitutive DNA-binding activity is largely composed of p50-c-Rel heterodimers.

In this paper we show that p50-c-Rel heterodimers have a greater propensity to be nuclear than p50-p65 heterodimers or either homodimer alone. Two properties of Rel and Ikappa B proteins dictate this preference. First, the NLSs of p65 and c-Rel homodimers are attenuated by association with Ikappa Balpha , while p50 provides a strong NLS and thereby increases nuclear import of heterodimers. Second, c-Rel does not contain a nuclear export sequence like p65; therefore, c-Rel-containing complexes are exported out of the nucleus less efficiently. We propose that the subunit composition of B-cell NF-kappa B reflects the inefficient retrieval of p50-c-Rel heterodimers from the nucleus. The question of retrieval only arises in B cells because c-Rel is sequestered in the cytoplasm of pre-B cells and non-B cells by association with Ikappa Bbeta . B-cell-specific association of c-Rel with Ikappa Balpha may further increase nuclear c-Rel because of Ikappa Balpha turnover. Thus, the presence of constitutive "NF-kappa B" in B-cell nuclei is the dynamic consequence of the properties of Rel and Ikappa B proteins.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell lines and strains. D5h3 T hybridoma cells, WEHI-231 (immature B) cells, and DC27 (mature T) cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, New York, N.Y.) supplemented with 10% heat-inactivated fetal bovine serum, 50 µM beta -mercaptoethanol, 50 U of penicillin per ml, and 50 µg of streptomycin per ml. A20 (mature B) cells, 70Z (pre-B) cells, M12 (mature B) cells, 22D6 (pre-B) cells, 38B9 (pre-B) cells, and 3A9 (mature T) cells were grown in RPMI 1640 medium (Gibco-BRL) with 10% heat-inactivated fetal bovine serum and the above supplements. COS cells were cultured in DMEM with 10% newborn calf serum and the above antibiotics. BOSC23 (human kidney epithelial cells) were maintained in DMEM with 10% heat-inactivated fetal bovine serum and antibiotics.

Splenic primary B cells were made by positively selecting mouse spleen cell suspensions using CD19 MicroBeads and MiniMACs with an MS column (Miltenyi Biotec). The sorted cells were then analyzed by flow cytometry, and over 95% of cells were CD19 positive. For splenic T cells, single-cell suspensions of mouse spleen cells were incubated with concanvalin A (4 µg/ml) (CalBiochem) for 3 days. Cells were then washed to remove concanavalin A and cultured in the presence of recombinant human interleukin-2 (IL-2) (50 U/ml) (BD Transduction Laboratories) for 7 days. Over 95% of T cells were T-cell receptor-beta positive by flow cytometry.

Plasmids. EGFP-p65 and pCDNA3.HA-Ikappa Balpha have been described previously (42). pCDNA3.HA-Ikappa Balpha LIL3A49(NESn) and HA-Ikappa Balpha NESnc were made by PCR using fragments from pGFP-Ikappa Balpha NESc and pGFP-Ikappa Balpha NESc-LIL3A49 (42) with a hemagglutinin (HA) tag containing 5' primer and 3' primer. The products were cloned into BamHI and EcoRI sites of pCDNA3 vector (Invitrogen Corporation). EGFP-p65(RHD) and EGFP-p65(364) contain mouse p65 (amino acids 1 to 306) and murine p65 (amino acids 1 to 364), respectively, in frame after the green fluorescent protein (GFP) gene of EGFP-C3 (Invitrogen Corporation) in the EcoRI and KpnI sites. EGFP-c-Rel, EGFP-c-Rel(RHD), and EGFP-c-Rel(344) contain full-length murine c-Rel, murine c-Rel (amino acids 1 to 297), mouse c-Rel (amino acids 1 to 344), respectively, in frame after GFP in the EcoRI and BamHI sites. The fragment in EGFP-p65(NES4A) was generated by PCR site-directed mutagenesis, with the four leucines at residues 434, 438, 441, and 443 changed to alanines and inserted in frame after GFP at EcoRI and XhoI sites. pCDNA3.hCRM1 was obtained by BamHI digestion of full-length human CRM1 cDNA clone in pBS-hCRM1 (a gift from G. Grosveld). pERVF2.p50 contained the full-length processed murine p50 (4), which was cloned after the cytomegalovirus promoter in plasmid pERVF2. The sequences of all plasmids used in this study were confirmed, and expression of proteins was verified by Western blot analysis.

Transfections. COS cell and BOSC23 cell transfection was done by the calcium phosphate method as previously described (32) or with Fugene-6 transfection reagent according to the manufacturer's specifications (Roche Molecular Biochemicals). Leptomycin B (LMB) (10 ng/ml), a generous gift from M. Yoshida (University of Tokyo), was added 4 h prior to harvest.

Immunoprecipitation. Cells were washed three times with phosphate-buffered saline (PBS). Whole-cell extracts were made by lysing the cells in TNT buffer (20 mM Tris-HCl [pH 7.5], 200 mM NaCl, 1% Triton X-100) with phosphatase and protease inhibitors. Then 100 µg of whole-cell extracts was incubated first with 30 µl of prewashed protein A-agarose beads in a 50% slurry (Roche Molecular Biochemicals) and then appropriate antibodies in TNT buffer with 0.1% Triton X-100 for 4 h. Anti-Ikappa Balpha , anti-c-Rel, and anti-p65 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.). The supernatants were subjected to secondary immunoprecipitation as indicated in the figure legends. The immunoprecipitates were washed three times with TNT buffer and eluted with 4 × sodium dodecyl sulfate (SDS) buffer by heating at 100°C for 5 min. The supernatants were separated by SDS-10% polyacrylamide gel electrophoresis (PAGE) for Western blot analysis.

Western blot analysis. Polyacrylamide gels were transferred to enhanced chemiluminescence Hybond nitrocellulose membrane (Amersham). The membranes were blocked with 5% milk in TBST buffer and then incubated with anti-c-Rel, anti-p65, or anti-Ikappa Balpha at a dilution of 1:500 for 1 h at room temperature. The membranes were washed and incubated with peroxidase-conjugated anti-rabbit Ig (Amersham) at a dilution of 1:2,000. The chemiluminescence signal was detected using SuperSignal substrate according to the manufacturer's specification (Pierce, Rockford, Ill.).

Immunostaining. The procedures for immunostaining of adherent cells were the same as described previously (42). For staining suspension cells (T cells and B cells), the procedures were described previously (8). Cells were allowed to settle on UV-sterilized coverslips (Fisher) with or without poly-L-lysine treatment (Sigma) overnight. LMB (100 ng/ml) was added 45 min prior to the staining. Cells were fixed in 3% paraformaldehyde for 20 min at room temperature and then permeabilized with buffer WB (0.5% NP-40, 0.01% sodium azide in 1 × PBS). The blocking was done with 5% normal donkey serum (Jackson Laboratory) at room temperature for 30 min. After blocking, the cells were incubated with primary antibodies in buffer WB with 5% normal donkey serum for 30 min at room temperature and then washed three times with buffer WB. The secondary antibody, fluorescein isothiocyanate (FITC)-conjugated anti-rabbit Ig (Jackson Laboratory) was used at a 1:300 dilution in WB with 5% normal donkey serum for 30 min at room temperature. After several washes 4',6'-diamidino-2-phenylindole (DAPI) (Molecular Probes, Eugene, Oreg.) was used at 1 µg/ml for counterstaining the nucleus. After further washing, the cells were mounted with ProLong Antifade (Molecular Probes) according to the manufacturer's specifications.

Fluorescence microscopy. The subcellular localization of GFP and the immunofluorescence signals were observed by fluorescence microscopy (Axiophot II; Zeiss) with a GFP generic filter, FITC, rhodamine, and DAPI filter.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Multiple factors contribute to cytosolic localization by Ikappa Balpha . We have previously shown that Ikappa Balpha contains an NES in its N-terminal domain, and cytosolic localization of p65 by Ikappa Balpha requires nuclear export. Ikappa Balpha also contains another NES in its C-terminal domain (1, 33, 37). To test whether these NESs were the only mediators of cytoplasmic localization, GFP-Rel proteins were coexpressed in COS cells with Ikappa Balpha derivatives mutated in one or both NESs. GFP-p65 was entirely cytoplasmic in the presence of wild-type Ikappa Balpha or derivatives mutated at the N-terminal NES (NESn) or both NESs (NESnc) (Fig. 1, top three panels). The observed cytoplasmic location was the result of nuclear export because treatment of the transfected cells with LMB led to nuclear accumulation of both p65 and Ikappa Balpha proteins (data not shown). Therefore, neither known NES sequence in Ikappa Balpha was essential for cytoplasmic retention of p65. We conclude that other CRM1-dependent export determinants were involved, which could lie within the ankyrin domains of Ikappa Balpha or in p65. Mutation of an NES in p65 identified by Harhaj and Sun (14) resulted in mixed nuclear and cytoplasmic distribution of the protein in the presence of Ikappa Balpha NESnc (Fig. 1B, top panel). Cytoplasmic expression of a complex that lacks all three NESs was more clearly evident in a C-terminal truncation mutant of p65, GFP-p65(364), which lacks the C-terminal NES. This protein was located in the cytoplasm in the presence of Ikappa Balpha NESnc. We conclude that nuclear export is not the only mechanism by which Ikappa Balpha regulates the subcellular distribution of p65.


View larger version (58K):
[in this window]
[in a new window]
  		FIG. 1.   Multiple determinants of cytosolic localization in p65-Ikappa Balpha protein complex. GFP-p65 and derivatives thereof were expressed in COS cells with HA-Ikappa Balpha (first row) or HA-Ikappa Balpha derivatives containing mutations at the N-terminal NES (NESn), or both N- and C-terminal NESs (NESnc), as indicated. Thirty-six hours after transfection, half of the cells were treated with LMB and fixed for fluorescent visualization. Columns show GFP fluorescence, anti-HA antibodies detected by rhodamine-coupled secondary antibody, and DAPI staining, respectively. GFP-p65NES4A contains four alanine residues replacing leucines in the C-terminal NES of p65; GFP-p65(RHD) contains the first 306 amino acids of p65 that include the RHD and the NLS (residues 301 to 304); GFP-p65(364) contains the first 364 amino acids of p65. All p65 derivatives were coexpressed with the doubly mutated Ikappa Balpha NESnc. Cells were fixed for fluorescent visualization as described in the text. Representative results are shown from one of three independent experiments.

A fusion protein containing only the RHD of p65, GFP-p65(RHD), was exclusively nuclear when coexpressed with Ikappa Balpha NESnc (Fig. 1B), but cytoplasmic in the presence of wild-type Ikappa Balpha (data not shown). Colocalization of the Ikappa Balpha derivatives with GFP-p65(RHD) suggested that the proteins were complexed (compare GFP and anti-HA fluorescence in Fig. 1B, third line); this was directly confirmed by coimmunoprecipitation (data not shown). Location of GFP-p65(364) in the cytoplasm but GFP-p65(306) in the nucleus when complexed to Ikappa Balpha NESnc suggested that Ikappa Balpha interaction with residues beyond the NLS of p65 (which is within the RHD) attenuated NLS function. Thus, the mutated Ikappa Balpha compensated for the attenuated NLS of GFP-p65(364) but not the exposed NLS of GFP-p65(RHD). These observations provide the first functional evidence for attenuation of the p65 NLS in complex with Ikappa Balpha . Use of an export-deficient Ikappa Balpha mutant was key in distinguishing the relative contributions of export and import in the net subcellular distribution of p65-Ikappa Balpha complexes.

Unlike GFP-65, GFP-c-Rel showed a mixed distribution (nucleus plus cytoplasm) in the presence of Ikappa Balpha NESnc (Fig. 2, third line). This pattern was similar to the NES-mutated p65 derivative, suggesting that c-Rel did not have an NES in its C-terminal domain. To directly compare CRM1 responsiveness of p65 and c-Rel, we coexpressed GFP derivatives of these proteins in BOSC23 cells together with human CRM1 (hCRM1) (Fig. 3). Both proteins were predominantly nuclear in the absence of CRM1; however, GFP-p65 but not GFP-c-Rel redistributed to the cytoplasm in the presence of hCRM1. This effect was mediated by the C-terminal NES of p65, because point mutations or deletion of this sequence made the protein unresponsive to hCRM1 (data not shown).


View larger version (70K):
[in this window]
[in a new window]
  		FIG. 2.   Multiple determinants of cytosolic localization in c-Rel-Ikappa Balpha protein complex. GFP-c-Rel and derivatives thereof were transiently transfected with HA-Ikappa Balpha (first row) or its derivative nuclear export mutant NESn or NESnc as described in the legend to Fig. 1. GFP-c-Rel(RHD) contains the first 297 residues of c-Rel that include the RHD and the NLS (residues 292 to 295). GFP-c-Rel(344) contains the first 344 residues of c-Rel. Thirty-six hours after transfection, cells were immunostained for fluorescent visualization. Results shown are representative of at least three independent experiments.


View larger version (24K):
[in this window]
[in a new window]
  		FIG. 3.   c-Rel does not contain a CRM1-dependent export sequence. BOSC23 cells were transiently transfected with expression plasmids encoding GFP-p65 or GFP-cRel proteins as indicated, with or without a plasmid encoding full-length hCRM1. The total amount of DNA used in transfections was normalized with empty vector. Thirty-six hours after transfection, cells were fixed for DAPI staining and fluorescence visualization. Results are from one of three independent experiments.

As observed with p65, the RHD of c-Rel, GFP-c-Rel(RHD), was exclusively nuclear in the presence of Ikappa Balpha NESnc, but a longer derivative had considerable cytoplasmic expression (Fig. 2B). Our interpretation is that the NLS of c-Rel(344) is attenuated by interaction with Ikappa Balpha , but that of the RHD is not. We conclude that p65 and c-Rel are similar to the extent that both NLSs are attenuated in association with Ikappa Balpha ; they are different in that p65 contains a C-terminal NES, but c-Rel does not. The biological implications of the differences are discussed below.

Effects of heterodimerization. The major cellular Rel-DNA complexes detected by mobility shift assays contain heterodimers of p65 or c-Rel with p50 or p52 (27, 30). To explore how the subunit composition of the Rel dimer affected subcellular localization, we coexpressed GFP-p65 or GFP-c-Rel with p50 and Ikappa Balpha . The GFP-p65-p50 heterodimer was located in the cytoplasm in the presence of either wild-type Ikappa Balpha (data not shown) or Ikappa Balpha NESn (Fig. 4). Mutation of the p65 NES did not affect the cytosolic location of the p65-p50 complex in the presence of wild-type Ikappa Balpha (data not shown), but resulted in nuclear localization of the Ikappa Balpha NESn-conaining heterotrimer (Fig. 4, fourth and fifth columns, second row).


View larger version (35K):
[in this window]
[in a new window]
  		FIG. 4.   Increased nuclear propensity of p50-c-Rel heterodimers. Left panels show the subcellular distribution of homodimers of GFP-p65 (first row), an NES-mutated GFP-p65 (second row), and GFP-c-Rel (third row) in the presence of HA-Ikappa Balpha NESn (Ikappa Balpha mutated in the N-terminal NES). Right panels show the distribution of heterodimers of these Rel proteins together with p50 in the presence of HA-Ikappa Balpha NESn. In all cases, GFP fluorescence colocalized with anti-HA, indicating that Ikappa Balpha was associated with the Rel homo- or heterodimers. All complexes were predominantly nuclear when the cells were treated with LMB for the last 3 h prior to harvest (data not shown). Results shown are from one of three independent experiments.

All cytosolic complexes moved to the nucleus when the cells were treated with LMB (data not shown), indicating that export was necessary to maintain NF-kappa B in the cytosol. Nuclear location of p50-p65NES heterodimers (Fig. 4, fourth column, second row) but not p65NES homodimers (Fig. 4, first column, second row) complexed to Ikappa Balpha NESn suggested that the p50 NLS was more effective at directing nuclear entry than the attenuated p65 NLS in an Ikappa Balpha -containing complex. We conclude that the p50 NLS is active in an NF-kappa B-Ikappa Balpha complex and that cytosolic location of the complex requires ongoing nuclear export.

The data in Fig. 2 and 3 showed that c-Rel does not contain an NES. Consistent with this, GFP-c-Rel-p50 complexes were retained in the cytoplasm by wild-type Ikappa Balpha (data not shown), but not Ikappa Balpha NESn (Fig. 4, third row). Because c-Rel homodimers were brought to the cytoplasm by Ikappa Balpha NESn, the nuclear location of p50-c-Rel heterodimers (Fig. 4, fourth column, third row) is most likely because the NLS of p50 is exposed in this complex. These observations suggest that various Rel homo- and heterodimers exhibit a hierarchy in their preference to be located in the cytoplasm when complexed to Ikappa Balpha . At one extreme, the (p65)2-Ikappa Balpha complex contains three NESs, which allows it to be removed most efficiently from the nucleus, while the p50-c-Rel-Ikappa Balpha complex contains only one NES, making it more likely to be nuclear. As shown below, this may be, in part, the explanation for the preferential location of p50-c-Rel complexes in the nuclei of B cells. Conversely, the propensity for nuclear export may define the ordered removal of Rel complexes from the nucleus at the end of cell stimulation.

Rel complexes in lymphocytes. From the studies described above, we drew two conclusions: first, that p65 and c-Rel differed in that p65 contained an NES while c-Rel did not, and second, that heterodimerization with p50 favored nuclear localization because its NLS was active when complexed to Ikappa Balpha . We propose that the subunit specificity of p50-c-Rel complexes in B-cell nuclei may be a consequence of inefficient export of this complex from the nucleus compared to p65-containing complexes. B-cell specificity of the phenomenon is a consequence of c-Rel association with Ikappa Balpha only in B cells (see below); this leads to increased c-Rel in the nucleus as it shuttles with Ikappa Balpha and because Ikappa Balpha is degraded more rapidly.

To identify c-Rel-associated Ikappa Bs, we carried out immunoprecipitations followed by immunoblotting. Whole-cell extracts from the indicated cells were immunoprecipitated with only one antibody or sequentially with two antibodies. The precipitates were fractionated by SDS-PAGE and immunoblotted with anti-c-Rel or anti-p65 antibodies. Anti-Ikappa Balpha coprecipitated c-Rel only from A20 (mature) B cells, but not from 70Z (pre-B) cells or D5h3 (T hybridoma) cells (Fig. 5A, left panels, lane 2). In contrast, c-Rel-Ikappa Bbeta association was detected in all these cell extracts (Fig. 5A, lane 4). Furthermore, preclearing the extracts with anti-Ikappa Bbeta removed all the c-Rel from 70Z and D5h3 extracts, confirming that there was an insignificant amount of Ikappa Balpha -associated c-Rel in these cells (Fig. 5A, lane 5). Conversely, preclearing with anti-Ikappa Balpha reduced the residual Ikappa Bbeta -associated c-Rel only in A20 extracts (Fig. 5A, lane 3). These observations indicate that c-Rel only associates with Ikappa Balpha in mature B cells. Unlike c-Rel, endogenous p65 was associated with both Ikappa Balpha and Ikappa Bbeta in all three cell lines (Fig. 5A, right panels).



View larger version (36K):
[in this window]
[in a new window]
  		FIG. 5.   c-Rel associates with Ikappa Balpha in mature B cells but not in pre-B cells and mature T cells. (A) Whole-cell extracts (100 µg) from mature B cells (A20), pre-B cells (70Z), or mature T cells (D5h3) were immunoprecipitated with nonspecific IgG (lane 1), anti-Ikappa Balpha antibody (lane 2), or anti-Ikappa Bbeta antibody (lane 4). For sequential immunoprecipitation, extracts were precleared with the first antibody and immunoprecipitated with the second antibody, as indicated above the lanes (lanes 3 and 5). Immunoprecipitates were separated by SDS-PAGE, and Rel proteins associated with Ikappa Bs were detected by immunoblotting. Left panel shows the results using anti-c-Rel and anti-Ikappa Balpha antibodies (Ab) to probe the blots; right panel was probed with anti-p65 and anti-Ikappa Balpha antibodies. Ikappa Bbeta protein was not assayed for because it comigrated with the Ig heavy-chain protein used for immunoprecipitation. Results are representative of at least three independent experiments. (B) Whole-cell extracts from indicated cells were analyzed by immunoprecipitation using nonspecific IgG (lane 1), anti-Ikappa Balpha (lane 2), and anti-Ikappa Bbeta (lane 3), followed by immunoblotting as described above. For each cell type, the upper panel shows the results using anti-c-Rel antibodies to probe the blots, and the lower panel shows the results of probing with anti-p65 antibodies. Top three rows correspond to cell lines representing pre-B, mature B, and T cells. Bottom row shows the analysis of primary splenic B and T cells purified as described in the text. Results are representative of at least two independent experiments with each cell type.

We further confirmed this trend in additional cell lines. In these studies, anti-Ikappa Balpha or anti-Ikappa Bbeta was used for immunoprecipitation. Ikappa B-associated proteins were fractionated by SDS-PAGE, and c-Rel or p65 was detected by immunoblotting. Ikappa Balpha -associated p65 was detected in six additional cell lines tested representing pre-B, mature B, and mature T cells (Fig. 5B, top three panels, lanes 2 and 5), as well as primary splenic B and T cells (Fig. 5B, bottom panel). Anti-Ikappa Bbeta also coprecipitated both c-Rel and p65 from all cells examined (Fig. 5B, lanes 3 and 6). However, Ikappa Balpha -associated c-Rel was only detected in mature B-cell lines and in splenic B cells (Fig. 5B, second and fourth rows, lanes 2 and 5), but not in pre-B, mature T, or splenic T cells. Taken together with the results in Fig. 5A, these observations suggest that c-Rel-Ikappa Balpha complexes are a unique feature of mature B lymphocytes.

The proposed model makes the additional prediction that p65 shuttles between the nucleus and the cytoplasm in most cells because it is associated with Ikappa Balpha , while c-Rel shuttles only in B cells. We tested this prediction using LMB to block CRM1-dependent export in the three cell lines used in Fig. 5A. Endogenous p65 was predominantly cytoplasmic in all three cell lines prior to treatment with LMB (Fig. 6A, left panels). In the presence of LMB, nuclear translocation of p65 was evident from its mixed nuclear and cytoplasmic distribution in all cells (Fig. 6A, right panels). The partial redistribution of p65 was probably because only a fraction of the total cytoplasmic pool of p65 was associated with Ikappa Balpha ; the rest that was associated with other Ikappa Bs did not shuttle, and therefore its subcellular location did not change with LMB. Immunostaining with anti-Ikappa Balpha and anti-Ikappa Bbeta antibodies confirmed that only Ikappa Balpha redistributed to the nucleus in response to LMB treatment of these cells (data not shown). Unlike p65, the predominantly cytoplasmic distribution of c-Rel in untreated cells was only altered in A20 cells after LMB treatment (Fig. 6B). Note that the constitutively nuclear c-Rel in A20 cells is difficult to discern in these figures because the majority of the protein, and consequently the imunofluorescence, is located in the cytoplasm. We conclude that the subcellular location of c-Rel in B cells is regulated by competing nuclear import and export. In contrast, c-Rel in other cell types is sequestered in the cytoplasm by Ikappa Bbeta or Ikappa Bvarepsilon .



View larger version (70K):
[in this window]
[in a new window]
  		FIG. 6.   c-Rel shuttles only in mature B cells. A20, D5h3, and 70Z cells were settled on poly-L-lysine-coated coverslips overnight. Half of the coverslips with attached cells were treated with LMB (100 ng/ml) for 45 min. Cells with and without LMB treatment were fixed and permeabilized for immunostaining with anti-p65 antibodies (A) or anti-c-Rel antibodies (B). Green fluorescence in the first and the third columns shows endogenous p65 (A) and endogenous c-Rel (B) of A20 (top row), 70Z (second row), and D5h3 (third row) cells before and after LMB treatment as indicated. Blue fluorescence in the second and fourth columns shows DAPI staining of nuclei. Results shown are from one of three independent experiments.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

We extended our earlier studies of nuclear-cytoplasmic dynamics of Rel-Ikappa B proteins to (i) compare the contribution of Rel proteins to export-dependent cytoplasmic localization and (ii) study the effects of heterodimerization on subcellular distribution. Our observations lead to a mechanism for the constitutive presence of nuclear p50-c-Rel heterodimers in B lymphocytes. The crux of our model is that inefficient export of p50-c-Rel heterodimers from B-cell nuclei may lead to accumulation of this protein in the nucleus. Why does this only happen in B cells, and what determines subunit specificity? We found that c-Rel is mainly associated with Ikappa Bbeta in non-B cells. The slow turnover rate of Ikappa Bbeta and its lack of nucleocytoplasmic shuttling ensure that this c-Rel rarely enters the nucleus.

In contrast, Ikappa Balpha -associated c-Rel in mature B cells can reach the nucleus in two ways. First, there is continuous generation of free p65 and c-Rel (homo- and p50-containing heterodimers) due to the higher turnover rate of Ikappa Balpha . These proteins translocate to the nucleus, from which they must be exported to maintain the cytoplasmic pool. This must be mediated by Ikappa Balpha , since the other Ikappa Bs do not have export potential. Newly synthesized Ikappa Balpha that migrates to the nucleus finds a DNA-binding competent pool of Rel homo- and heterodimers with which to associate. We propose that the absence of an NES in c-Rel is manifest at this stage, and c-Rel is exported out of the nucleus less efficiently than p65. Association with p50 further enhances nuclear propensity of p50-c-Rel heterodimers because the p50 NLS is not attenuated by Ikappa Balpha . The proposed discrimination based on efficiency of export suggests that export capacity is limiting under these conditions. At present we cannot distinguish whether the limitation is at the level of the export machinery or the export chaperone Ikappa Balpha . Second, Ikappa Balpha -associated c-Rel also enters the nucleus, because the complexes shuttle. Once in the nucleus, some of these complexes may dissociate if, for example, export is limiting and the intact complex is not rapidly removed. Again, the reduced export potential of c-Rel-containing complexes compared to p65-containing complexes would skew the subunit composition of the resulting DNA-binding activity towards c-Rel. Thus, B-cell-specific nuclear NF-kappa B is the dynamic consequence of the combined properties of Rel, Ikappa B, and cellular export proteins.

Antibody accessibility studies had first led to the model that cytoplasmic retention of NF-kappa B by Ikappa Bs was the result of hiding the NLSs present on the Rel proteins (45). While this may be true for Ikappa Bbeta and Ikappa Bvarepsilon (43), it is clear that functional NLS activity is present in Rel-Ikappa Balpha complexes, which undergo nucleocytoplasmic shuttling. Moreover, the finding that Ikappa Balpha -dependent nuclear export is the major mechanism of cytoplasmic "retention" by Ikappa Balpha circumvents the necessity to hide NLSs in Rel-Ikappa Balpha complexes. This raises the question of whether association with Ikappa Balpha affects the NLS of Rel proteins at all.

The crystal structure of the NF-kappa B-Ikappa Balpha complex shows that Ikappa Balpha is oriented such that the first two ankyrin domains contact the C terminus of the RHDs of p65 and p50 (17, 18). This interaction forces a 19-amino-acid stretch of p65 that contains the NLS into two alpha -helices (18). The NLS is located at the end of the first helix, and three of its side chains make salt bridges with Ikappa Balpha . The close association of Ikappa Balpha and the p65 NLS is consistent with inactivation or attenuation of NLS function. The NLS of p50 does not contact Ikappa Balpha , leading to the speculation that it may be occluded indirectly to keep the p50-p65 complex in the cytoplasm (5).

We provide the first functional evidence that the NLSs of both p65 and c-Rel are attenuated by association with Ikappa Balpha . This conclusion follows from the observation that the RHDs of p65 and c-Rel were nuclear in the presence of an NES-mutated Ikappa Balpha derivative, whereas longer Rel proteins were located in the cytoplasm. Use of the NES-mutated Ikappa Balpha in these studies was essential to distinguish export- from import-dependent cytoplasmic location. Because export did not play a role in the subcellular distribution of these complexes, our interpretation is that the nuclear import potential of longer Rel proteins is reduced when they are complexed to Ikappa Balpha . This is most likely due to the secondary structure that is induced in the p65 NLS by Ikappa Balpha when residues beyond the RHD are present (18). Recent biochemical studies also show that these additional residues contribute to Ikappa Balpha binding to p65 (35).

We also present evidence that the p50 NLS is functionally available and mediates nuclear entry of p50-p65-Ikappa Balpha and p50-c-Rel-Ikappa Balpha complexes. These observations offer no evidence for "indirect" occlusion of the p50 NLS. Rather, cytoplasmic location of the heterodimers must involve compensation of the p50 NLS by the export potential of the Ikappa Balpha NES. In other studies we have found that the p65 NES is weaker than the Ikappa Balpha NES (W. Tam, unpublished observations). This makes good sense because a strong NES in p65 would make this protein constitutively cytoplasmic even in the absence of Ikappa Balpha . Instead, the weaker NES accentuates nuclear exit in the presence of Ikappa Balpha , but is dominated by the unattenuated NLS in the absence of Ikappa Balpha . Modulating the strength of NESs and NLSs in Rel and Ikappa B family members presumably allows the appropriate balance of nuclear and cytoplasmic expression of NF-kappa B proteins.

Our observations indicate a hierarchy of nuclear propensity among Rel homo- and heterodimers which is based on the presence or absence of NESs and association with p50. For example, p65 homodimers contain two NESs and two unattenuated NLSs; (p65)2 complexes are predominantly nuclear because the NLSs dominate. Association with Ikappa Balpha attenuates the NLSs and adds an additional NES; the result is location in the cytoplasm. Compared to p65, c-Rel has a greater tendency to be nuclear because it lacks a well-defined NES. Association with p50 further accentuates this by providing an NLS that is active even when complexed to Ikappa Balpha . As described above, one consequence of this hierarchy is to enrich c-Rel-p50 complexes in B-cell nuclei. We speculate that this hierarchy may also dictate the efficiency by which Rel proteins are removed from the nucleus at the end of cell stimulation. Accordingly, p65 homodimers would be removed most efficiently, followed by c-Rel homodimers, followed by p50-p65 and p50-c-Rel heterodimers. One reason may be that the most potent transcription activator must be downregulated effectively for the cell to reach its resting state.


    ACKNOWLEDGMENTS

The human CRM1 gene and LMB were kindly provided by G. Grosveld and M. Yoshida (University of Tokyo), respectively. We thank Phil Gnatowski for help in preparation of the manuscript.

This work was supported by NIH grant AI-41035 to R.S.


    FOOTNOTES

* Corresponding author. Mailing address: Rosenstiel Basic Medical Sciences Research Center and Department of Biology, Brandeis University, Waltham, MA 02454. Phone: (781) 736-2454. Fax: (781) 736-2405. E-mail: sen{at}brandeis.edu.

dagger Present address: Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Arenzana-Seisdedos, F., P. Turpin, M. Rodriguez, D. Thomas, R. T. Hay, J. L. Virelizier, and C. Dargemont. 1997. Nuclear localization of Ikappa Balpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J. Cell Sci. 110:369-378[Abstract].
2. Bajpai, U. D., K. Zhang, M. Teutsch, R. Sen, and H. H. Wortis. 2000. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappa B activation. J. Exp. Med. 191:1735-1744[Abstract/Free Full Text].
3. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in Ikappa Balpha -deficient mice. Genes Dev. 9:2736-2746[Abstract/Free Full Text].
4. Blank, V., P. Kourilsky, and A. Israel. 1991. Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J. 10:4159-4167[Medline].
5. Cramer, P., and C. W. Muller. 1999. A firm hand on NFkappa B: structures of the Ikappa Balpha -NFkappa B complex. Structure Fold Des. 7:R1-R6[Medline].
6. Doerre, S., and R. B. Corley. 1999. Constitutive nuclear translocation of NF-kappa B in B cells in the absence of Ikappa B degradation. J. Immunol. 163:269-277[Abstract/Free Full Text].
7. Ellmeier, W., S. Jung, M. J. Sunshine, F. Hatam, Y. Xu, D. Baltimore, H. Mano, and D. R. Littman. 2000. Severe B cell deficiency in mice lacking the Tec kinase family members Tec and Btk. J. Exp. Med. 192:1611-1624[Abstract/Free Full Text].
8. Feske, S., R. Draeger, H. H. Peter, K. Eichmann, and A. Rao. 2000. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J. Immunol. 165:297-305[Abstract/Free Full Text].
9. Fields, E. R., B. J. Seufzer, E. M. Oltz, and S. Miyamoto. 2000. A switch in distinct Ikappa Balpha degradation mechanisms mediates constitutive NF-kappa B activation in mature B cells. J. Immunol. 164:4762-4767[Abstract/Free Full Text].
10. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J. Y. Scheerlinck, and R. J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93:3405-3409[Abstract/Free Full Text].
11. Grossmann, M., Y. Nakamura, R. Grumont, and S. Gerondakis. 1999. New insights into the roles of Rel/NFkappa B transcription factors in immune function, hemopoiesis and human disease. Int. J. Biochem. Cell Biol. 31:1209-1219[CrossRef][Medline].
12. Grossmann, M., L. A. O'Reilly, R. Gugasyan, A. Strasser, J. M. Adams, and S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19:6351-6360[CrossRef][Medline].
13. Grumont, R. J., and S. Gerondakis. 1994. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 5:1321-1331[Abstract].
14. Harhaj, E. W., and S. C. Sun. 1999. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:7088-7095[Abstract/Free Full Text].
15. Hay, R. T., L. Vuillard, J. M. Desterro, and M. S. Rodriguez. 1999. Control of NF-kappa B transcriptional activation by signal induced proteolysis of Ikappa Balpha . Phil. Trans. R. Soc. Lond. B Biol. Sci. 354:1601-1609[CrossRef][Medline].
16. Huang, T. T., N. Kudo, M. Yoshida, and S. Miyamoto. 2000. A nuclear export signal in the N-terminal regulatory domain of Ikappa Balpha controls cytoplasmic localization of inactive NF-kappa B/Ikappa Balpha complexes. Proc. Natl. Acad. Sci. USA 97:1014-1019[Abstract/Free Full Text].
17. Huxford, T., D. B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the Ikappa Balpha /NF-kappa B complex reveals mechanisms of NF-kappa B inactivation. Cell 95:759-770[CrossRef][Medline].
18. Jacobs, M. D., and S. C. Harrison. 1998. Structure of an Ikappa Balpha /NF-kappa B complex. Cell 95:749-758[CrossRef][Medline].
19. Johnson, C., D. Van Antwerp, and T. J. Hope. 1999. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of Ikappa Balpha EMBO J. 18:6682-6693[CrossRef][Medline].
20. Kerner, J. D., M. W. Appleby, R. N. Mohr, S. Chien, D. J. Rawlings, C. R. Maliszewski, O. N. Witte, and R. M. Perlmutter. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301-312[CrossRef][Medline].
21. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283-299[CrossRef][Medline].
22. Kistler, B., A. Rolink, R. Marienfeld, M. Neumann, and T. Wirth. 1998. Induction of nuclear factor-kappa B during primary B cell differentiation. J. Immunol. 160:2308-2317[Abstract/Free Full Text].
23. Klaus, G. G., M. Holman, C. Johnson-Leger, C. Elgueta-Karstegl, and C. Atkins. 1997. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur. J. Immunol. 27:2749-2756[Medline].
24. Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, P. H. Bhatt, C. H. Chen, C. A. Rosen, and C. L. Stewart. 1996. Ikappa Balpha deficiency results in a sustained NF-kappa B response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349[Abstract].
25. Krappmann, D., and C. Scheidereit. 1997. Regulation of NF-kappa B activity by Ikappa Balpha and Ikappa Bbeta stability. Immunobiology 198:3-13[Medline].
26. Liou, H. C., Z. Jin, J. Tumang, S. Andjelic, K. A. Smith, and M. L. Liou. 1999. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11:361-371[Abstract/Free Full Text].
27. Liou, H. C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349-5359[Abstract/Free Full Text].
28. May, M. J., and S. Ghosh. 1997. Rel/NF-kappa B and Ikappa B proteins: an overview. Semin. Cancer Biol. 8:63-73[CrossRef][Medline].
29. Miyamoto, S., P. J. Chiao, and I. M. Verma. 1994. Enhanced Ikappa Balpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell. Biol. 14:3276-3282[Abstract/Free Full Text].
30. Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056-5060[Abstract/Free Full Text].
31. Miyamoto, S., B. J. Seufzer, and S. D. Shumway. 1998. Novel Ikappa Balpha proteolytic pathway in WEHI231 immature B cells. Mol. Cell. Biol. 18:19-29[Abstract/Free Full Text].
32. Nelsen, B., G. Tian, B. Erman, J. Gregoire, R. Maki, B. Graves, and R. Sen. 1993. Regulation of lymphoid-specific immunoglobulin µ heavy chain gene enhancer by ETS-domain proteins. Science 261:82-86[Abstract/Free Full Text].
33. Ossareh-Nazari, B., F. Bachelerie, and C. Dargemont. 1997. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278:141-144[Abstract/Free Full Text].
34. Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18:6853-6866[CrossRef][Medline].
35. Phelps, C. B., L. L. Sengchanthalangsy, T. Huxford, and G. Ghosh. 2000. Mechanism of Ikappa Balpha binding to NF-kappa B dimers. J. Biol. Chem. 275:29840-29846[Abstract/Free Full Text].
36. Phillips, R. J., and S. Ghosh. 1997. Regulation of Ikappa Bbeta in WEHI 231 mature B cells. Mol. Cell. Biol. 17:4390-4396[Abstract].
37. Prigent, M., I. Barlat, H. Langen, and C. Dargemont. 2000. Ikappa Balpha and Ikappa Balpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J. Biol. Chem. 275:36441-36449[Abstract/Free Full Text].
38. Satterthwaite, A. B., Z. Li, and O. N. Witte. 1998. Btk function in B cell development and response. Semin. Immunol. 10:309-316[CrossRef][Medline].
39. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321-330[CrossRef][Medline].
40. Shumway, S. D., M. Maki, and S. Miyamoto. 1999. The PEST domain of Ikappa Balpha is necessary and sufficient for in vitro degradation by µ-calpain. J. Biol. Chem. 274:30874-30881[Abstract/Free Full Text].
41. Snapper, C. M., P. Zelazowski, F. R. Rosas, M. R. Kehry, M. Tian, D. Baltimore, and W. C. Sha. 1996. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:183-191[Abstract].
42. Tam, W. F., L. H. Lee, L. Davis, and R. Sen. 2000. Cytoplasmic sequestration of Rel proteins by Ikappa Balpha requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20:2269-2284[Abstract/Free Full Text].
43. Tam, W. F., and R. Sen. 2001. Ikappa B family member function by different mechanisms. J. Biol. Chem. 276:7701-7704[Abstract/Free Full Text].
44. Whiteside, S. T., and A. Israel. 1997. Ikappa B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75-82[CrossRef][Medline].
45. Zabel, U., T. Henkel, M. S. Silva, and P. A. Baeuerle. 1993. Nuclear uptake control of NF-kappa B by MAD-3, an Ikappa B protein present in the nucleus. EMBO J. 12:201-211[Medline].

Molecular and Cellular Biology, July 2001, p. 4837-4846, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4837-4846.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles: